Human medicines European public assessment report (EPAR): Locametz, gozetotide, Radionuclide Imaging, Date of authorisation: 09/12/2022, Status: Authorised

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Radionuclide Imaging, Date of authorisation: 09/12/2022, Status: Authorised

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Radionuclide Imaging, Date of authorisation: 09/12/2022, Status: Authorised

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Radionuclide Imaging, Date of authorisation: 09/12/2022, Status: Authorised

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Radionuclide Imaging, Date of authorisation: 09/12/2022, Status: Authorised

Wil je het laatste nieuws in jouw mailbox ontvangen?
Meld je dan aan voor de nieuwsbrief.